Angel Lanas1, Juan-V Esplugues, Javier Zapardiel, Eduardo Sobreviela. 1. Service of Digestive Diseases, University Hospital, University of Zaragoza, Instituto Aragonés de Ciencias de Salud, Centros de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), C/San Juan Bosco 15, 50009 Zaragoza, Spain. alanas@unizar.es
Abstract
AIM: To evaluate an evidence-based educational program for improving strategies for prevention of nonsteroidal anti-inflammatory drug (NSAID)-associated gastrointestinal (GI) complications. METHODS: Four hundred and fifty-six specialists replied to a questionnaire that covered issues related to NSAID-induced adverse effects. They also collected data from their last five consecutive patients before and after they had attended an evidence-based seminar on GI prevention strategies. RESULTS: Four hundred and forty-one of 456 specialists (96.7%) participated in the survey, and 382 (83.7%) in the education-based study that recorded data from 3728 patients. The specialists overestimated the risk of GI complications with NSAIDs, underestimated the GI safety profile of coxibs, but were aware of the risk factors and of the current prevention strategies. Proton pump inhibitors were co-prescribed with NSAIDs in > 80% of patients with and without risk factors. The educational program had little impact on prescribing habits. CONCLUSION: Specialists are informed of advances in NSAID-associated adverse effects and have high rates of GI-prevention therapy. Our educational program did not alter these rates.
AIM: To evaluate an evidence-based educational program for improving strategies for prevention of nonsteroidal anti-inflammatory drug (NSAID)-associated gastrointestinal (GI) complications. METHODS: Four hundred and fifty-six specialists replied to a questionnaire that covered issues related to NSAID-induced adverse effects. They also collected data from their last five consecutive patients before and after they had attended an evidence-based seminar on GI prevention strategies. RESULTS: Four hundred and forty-one of 456 specialists (96.7%) participated in the survey, and 382 (83.7%) in the education-based study that recorded data from 3728 patients. The specialists overestimated the risk of GI complications with NSAIDs, underestimated the GI safety profile of coxibs, but were aware of the risk factors and of the current prevention strategies. Proton pump inhibitors were co-prescribed with NSAIDs in > 80% of patients with and without risk factors. The educational program had little impact on prescribing habits. CONCLUSION: Specialists are informed of advances in NSAID-associated adverse effects and have high rates of GI-prevention therapy. Our educational program did not alter these rates.
Authors: Jay L Goldstein; Kimberly B Howard; Surrey M Walton; Trent P McLaughlin; Denise T Kruzikas Journal: Clin Gastroenterol Hepatol Date: 2006-11 Impact factor: 11.382
Authors: W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell Journal: Osteoarthritis Cartilage Date: 2008-02 Impact factor: 6.576
Authors: Gregory A Coté; John P Rice; William Bulsiewicz; John P Norvell; Keri Christensen; Anne Bobb; Michael Postelnick; Colin W Howden Journal: Am J Gastroenterol Date: 2008-05 Impact factor: 10.864
Authors: Meldon Kahan; Tara Gomes; David N Juurlink; Michael Manno; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava; Rhoda Reardon; Irfan A Dhalla; Muhammad M Mamdani Journal: Can Fam Physician Date: 2013-05 Impact factor: 3.275
Authors: Jacob E Kurlander; Danielle Helminski; Michael Lanham; Jennifer L Henstock; Kelley M Kidwell; Sarah L Krein; Sameer D Saini; Caroline R Richardson; Raymond De Vries; Kenneth Resnicow; Allison Laboon Ruff; David M Wallace; Elizabeth K Jones; Linda K Perry; Jacqueline Parsons; Nghi Ha; Tina Alexandris-Souphis; Dale Dedrick; Elizabeth Aldridge; Geoffrey D Barnes Journal: Implement Sci Commun Date: 2022-01-28
Authors: Azizah M Malebari; Ahdab N Khayyat; Ruba A Mahdali; Jumana S Alamoudi; Bushra Y Alsayed; Samar A Alrasheed Journal: Saudi Med J Date: 2020-08 Impact factor: 1.484